Lactate metabolism reprogramming in PDAC: Potential for tumor therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-09 · 1880 (4) · 189373
DOI: 10.1016/j.bbcan.2025.189373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-09. Verfasst von Fan Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Lactic Acid. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key R&D Plan in Zhejiang Province.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. During tumor progression, metabolic reprogramming plays a crucial role in both tumor proliferation and immune evasion. In PDAC, genetic mutations and environment limitations lead to resulting in increased lactate production through enhanced glycolysis. Elevated glycolysis is a significant metabolic feature in pancreatic cancer, leading to lactate accumulation within both the tumor cells and tumor immune microenvironment. Lactate not only promotes tumor growth and sustains its survival but also has a profound impact on the immune-suppressive phenotype switch of immune cells. Lactate promotes tumor progression through various biological processes. Pharmacological agents targeting lactate generation, accumulation and lactate-related molecular pathways show potential clinical translation value in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease, the…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Key R&D Plan in Zhejiang Province
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Program of Zhejiang Province
- Science and Technology Department of Zhejiang Province
Zitieren
APA
Gao, F., Sun, K., Wang, S., Zhang, X., & Bai, X. (2025). Lactate metabolism reprogramming in PDAC: Potential for tumor therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(4), 189373. https://doi.org/10.1016/j.bbcan.2025.189373
Vancouver
Gao F, Sun K, Wang S, Zhang X, Bai X. Lactate metabolism reprogramming in PDAC: Potential for tumor therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(4):189373. doi:10.1016/j.bbcan.2025.189373
BibTeX
@article{Gao2025,
author = {Gao, Fan and Sun, Kang and Wang, Sicheng and Zhang, Xiaozhen and Bai, Xueli},
title = {Lactate metabolism reprogramming in PDAC: Potential for tumor therapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {4},
pages = {189373},
doi = {10.1016/j.bbcan.2025.189373}
}
EUVIMED